Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
huangzhihua oral liquid
- Development stage
- Unknown
- Lead developer
- Jiangsu Kanion Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Huangzhihua Oral Liquid is a Traditional Chinese Medicine (TCM) developed by Jiangsu Kanion Pharmaceutical, primarily indicated for the treatment of neonatal jaundice (hyperbilirubinemia). The formulation is composed of extracts from *Scutellaria baicalensis* (Huangqin), *Gardenia jasminoides* (Zhizi), *Lonicera japonica* (Jinyinhua), and *Rheum palmatum* (Dahuang). It functions by clearing heat, detoxifying the body, and removing dampness-heat, which facilitates the excretion of bilirubin through the gallbladder and intestines. It is widely used in pediatric clinical practice in China as an adjuvant or primary therapy for damp-heat type jaundice, often in combination with phototherapy to accelerate the reduction of serum bilirubin levels.
- Brand names
- Huangzhihua
- Other names
- Huangzhihua Koufuye黄栀花口服液
Beyond the preview
Go deeper on huangzhihua oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on huangzhihua oral liquid.